The p21-activated kinase 2 (Pak2), an effector molecule of the Rho family GTPases Rac and Cdc42, regulates diverse functions of T cells. Previously, we showed that Pak2 is required for development and maturation of T cells in the thymus, including thymus-derived regulatory T (Treg) cells. However, whether Pak2 is required for the functions of various subsets of peripheral T cells, such as naive CD4 and helper T-cell subsets including 
Introduction
Antigen recognition by the T-cell receptor (TCR) stimulates a variety of intracellular signalling pathways in T cells, ultimately leading to proliferation of T cells. [1] [2] [3] [4] [5] [6] Among these signalling pathways, Rho family GTPases regulate actin cytoskeleton rearrangement associated with T-cell activation, while mitogen-activated protein kinase and mammalian target of rapamycin (mTOR) play a key role in T-cell proliferation. Once T cells are activated, they increase expression of CD25, CD69 and CD40L, and produce cytokines such as interleukin-2 (IL-2), which subsequently provide additional proliferative signals to T cells. 7 TCR stimulation of naive CD4 T cells in the presence of various cytokines provides signals differentiating them into specialized effector cells such as T helper type 1 (Th1) [with IL-12 or interferon-c (IFN-c)], Th2 (with IL-4), Th17 [with IL-6 and transforming growth factor-b (TGF-b)] and induced regulatory T (iTreg) cells (with IL-2 and TGF-b). 1, 8 Moreover, TCR provides the signals required for maintenance of T cells.
P21-activated kinases (Paks) are serine-threonine kinases that phosphorylate multiple substrates involved in proliferation, migration and cytoskeletal reorganization. 9, 10 Pak2 is robustly activated after TCR engagement and regulates T-cell development, activation and function. 9, 10 Inhibition of Pak2 by overexpressing mutant forms of Pak2 inhibited TCR-induced up-regulation of CD69, calcium influx and nuclear factor of activated T cells activity in Jurkat cells, or IL-2 production in mouse primary T cells. 11 Furthermore, Pak2 is required for T-cell development and maturation in the thymus by coordinating actin cytoskeletal reorganization. 12 Moreover, Pak2 is critical for the development of thymusderived Treg (tTreg) cells 13 and natural killer T cells 14 by controlling signals crucial for lineage differentiation. For instance, Pak2 is essential for transducing high-affinity TCR signals for the development of tTreg cells. Given Pak2 0 s roles regulating the development and activation of multiple T-cell subsets in the thymus, Pak2 may regulate the function of T-cell subsets in the periphery. However, it is still unknown whether Pak2 regulates T-cell function in the periphery due to the embryonic lethality of Pak2 knockout (KO) mice 14 and severe T-cell deficiency in T-cell-specific conditional KO mice. 15 Here, we demonstrated that Pak2 is specifically required for the maintenance of Foxp3 + Treg cells in the periphery using tamoxifen-inducible Pak2 KO mouse models. Temporal deletion of Pak2 in CD4 T cells by administration of tamoxifen reduced the number of Foxp3 + Treg cells, but not conventional T cells in the periphery. Proliferation of Foxp3 + Treg cells and maintenance of Foxp3 expression under TCR and IL-2 stimulation conditions required Pak2. Likewise, Pak2 was also required for proliferation of CD4 T cells following TCR stimulation and differentiation of CD4 effector T cells such as iTreg cells and Th17 cells. Mechanistically, phosphorylation of cofilin, p70S6K and S6 were markedly reduced in Pak2-deficient CD4 T cells, suggesting that Pak2 regulates actin cytoskeletal reorganization and activation of the mTORC1 pathway upon TCR activation. These findings reveal the role of Pak2, a protein regulating actin cytoskeletal reorganization, in the control of peripheral Foxp3 + Treg cells through the regulation of TCR-mediated activation, proliferation, differentiation and maintenance.
Materials and methods

Mice UBC-ER
T2
-Cre and Rosa26-YFP mice were described previously. 13 Cd4-ER
-Cre mice were from Dr Fontini Gounari at the University of Chicago 16 and Pak2
F/F
;Cd4-ER T2 -Cre;Rosa26-YFP mice were generated by mating the Pak2 F/F , Cd4-ER
T2
-Cre and Rosa26-YFP mice. Genotyping of the mice was performed by genomic PCR as described previously.
13 C57BL/6 and Rag1 À/À mice were obtained from Jackson Laboratory (Bar Harbor, ME). All mice were housed in the specific pathogen-free facility at Northwestern University and used under the animal study protocol approved by the University Animal Care Use Committee (2012-2851).
Tamoxifen-inducible deletion of Pak2
To induce tamoxifen-mediated deletion, Pak2 F/F ;Cd4-ER T2 -Cre;Rosa26-YFP or Pak2 F/F ;UBC-ER T2 -Cre;Rosa26-YFP mice were treated with tamoxifen dissolved in corn oil (100 mg/kg; Sigma, St Louis, MO) by oral gavage for 5 consecutive days as described previously. 13 Animals were killed for analysis after a 5-day rest period. Pak2 For iTreg cell differentiation, 1 9 10 6 cells/well were cultured in 24-well plates with 2 lg/ml pre-coated anti-CD3 (2C11; BD) and 2 lg/ml soluble anti-CD28 (37Á51; BD) antibodies, 10 U/ml IL-2 (NIH, Bethesda, MD) and 10 ng/ml recombinant human TGF-b 1 (R&D Systems, Minneapolis, MN) for 3 days. For Th1 differentiation, 1 9 10 6 cells/well were cultured in 24-well plates with precoated anti-CD3 and soluble anti-CD28 antibodies, 10 U/ ml IL-2, 10 ng/ml IL-12 (R&D Systems) and 10 lg/ml anti-IL-4 antibody (R&D Systems) for 3 days. After 3 days of incubation, the cells were split in a 1 : 2 ratio with fresh IL-2 medium and incubated for another 2 days. For Th17 differentiation, 5 9 10 5 cells/well were cultured in 24-well plates with pre-coated anti-CD3 and anti-CD28 antibodies in the presence of 1 ng/ml human TGF-b 1 , 100 ng/ml IL-6, 50 ng/ml IL-23, 10 lg/ml anti-IL-4 antibody and 20 lg/ml anti-IFN-c antibody for 3 days. For the cytokine analysis, the cells were stimulated with 50 ng/ml PMA and 1 lM ionomycin for 5 hr.
For proliferation assay, CD4 + CD25 À T cells or CD4 + CD25 + CD45RB low Treg cells were washed with PBS and labelled with a proliferation dye eFluor450 (eBioscience) for 20 min at room temperature. The cells were then washed twice with RPMI-1640 containing 10% FBS. The appropriate number of dye-labelled cells was used for activation, T helper differentiation or homeostatic proliferation.
In vivo homeostatic proliferation assay
CD4
+ CD25 À T cells were isolated from either Pak2 F/F ; UBC-ER T2 -Cre;Rosa26-YFP or Pak2 F/F control mice. The cells were labelled with a proliferation dye eFlour450 as described above and then mixed together in a 1 : 1 ratio. In total, 1 9 10 5 cells were adoptively transferred into Rag1 À/À mice. One week later, proliferation of transferred cells was measured by flow cytometry. 
Flow cytometry
Statistical analysis
All experiments were performed more than twice. Statistical analysis and graphs were generated using PRISM6 (GraphPad, La Jolla, CA).
Results
Temporal deletion of Pak2 inhibits homeostasis of peripheral Treg cells
Previously, we found that numbers and percentages of tTreg cells in the thymus were greatly reduced in the absence of Pak2 in T cells using Cd4-Cre or Lck-Cre transgenic mice, demonstrating that Pak2 is required for development of tTreg cells. However, severe T-cell deficiency in these models makes it difficult to assess the in vivo role of Pak2 in regulating T-cell function. We previously were able to delete Pak2 temporarily and assess the effect of loss of Pak2 using ex vivo T cells from Pak2 (Fig. 1c) . Unexpectedly, we found that purified YFP À CD4 T cells from the same mice also decreased Pak2 expression (Fig. 1c, Since TCR and IL-2 signals are important for proliferation and homeostasis of Foxp3 + Treg cells in the periphery, [17] [18] [19] -Cre;Rosa26-YFP mice are indicated in red (*P < 0Á05; **P < 0Á01; ***P < 0Á001; ns, non-significant 13 Consistent with our previous data, differentiation of iTreg cells was greatly impaired in Pak2 F/F ;Cd4-ER T2 -Cre;Rosa26-YFP mice (Fig. 3a) . Induction of Foxp3, CD25 and CTLA4 was impaired when naive Pak2 KO CD4 T cells were differentiated into iTreg cells (Fig. 3b) . When Foxp3 + cells were gated to identify Foxp3 + iTreg cells from CD4 T cells, CTLA4 was substantially decreased in the absence of Pak2, whereas the levels of Foxp3, CD25 and GITR were comparable between WT and KO iTreg cells (Fig. 3c) . We measured percentages of live cells by Live/Dead staining and AnnexinV for apoptosis marker to determine if the Pak2 effect on iTreg differentiation is caused by cell death. The percentages of AnnexinV Pak2 is due to a defect in induction of iTreg cells under differentiation conditions. Next, we examined the proliferation of CD4 T cells and induction of Foxp3 + under iTreg differentiation conditions. The absence of Pak2 impaired the proliferation of CD4 T cells and lowered at least three cycles of cell division under iTreg differentiation conditions (Fig. 3d) . Interestingly, although proliferation was impaired in Pak2 KO CD4 T cells under iTreg conditions, the cells underwent several divisions of proliferation without increasing Foxp3 (Fig. 3e, upper panel) , suggesting that even TCRactivated and proliferated Pak2 KO CD4 T cells fail to increase Foxp3. To determine induction of Foxp3 in CD4 T cells that are equally activated by TCR stimulation, we gated cells with similar expression levels of CD25. Seventy per cent of Pak2 KO CD4 T cells was able to increase CD25, suggesting a partial effect of Pak2 deficiency in CD4 T-cell activation (Fig. 3e) . On the contrary, induction of Foxp3 in Pak2 KO T cells was markedly decreased even in CD25-expressing activated T cells, indicating that Pak2 is required to induce Foxp3 in iTreg cells (Fig. 3f) . Hence, Pak2 regulates differentiation of iTreg cells from naive peripheral CD4 T cells by controlling the induction of Foxp3.
Naive CD4 T cells can also differentiate into other subsets of effector cells when cells are stimulated with the appropriate cytokine milieu. 8 Because we found that differentiation of iTreg cells was impaired in the absence of Pak2, we asked whether Pak2 is required for the differentiation of Th1 and Th17, which are critical for inflammation. (Fig. 4a,b) .
We also tested the role of Pak2 in CD8 T-cell proliferation. Approximately 45% of CD8 + T cells of Pak2 -Cre mice were cultured for 3 days with CD3/CD28 stimulation. Proliferation of CD8 T cells also required Pak2, but the effect of Pak2 deficiency on CD8 T cells was not as severe as the effect on the CD4 T cells because some percentages of CD8 T cells were able to proliferate (Fig. 4c) . Interleukin-2 plays a critical role in CD4 T-cell proliferation upon TCR stimulation. Expression of IL-2 was significantly decreased in TCR-stimulated Pak2 KO CD4 T cells (Fig. 4d) . These results suggest that Pak2 is required for TCR-induced IL-2 production and subsequent proliferation of CD4 T cells. Addition of exogenous IL-2 to the culture of Pak2 KO CD4 T cells with CD3/CD28 stimulation increased the expression of a high affinity IL-2 receptor a (CD25) from 17% to 60% but failed to completely recover proliferation (Fig. 4e) . Deletion of Pak2 inhibits phosphorylation of cofilin, p70S6K and S6 in CD4 T cells
Previously, we showed that Pak2 is required for phosphorylation of PLCc and ERK in CD4 single-positive thymocytes when stimulated with plate-bound anti-CD3/ CD28.
12
To elucidate underlying mechanism of the role of Pak2 in TCR-mediated activation and proliferation, we investigated whether similar signalling pathways were affected in peripheral T cells. In contrast with CD4 single-positive thymocytes, we found that phosphorylation of PLCc and ERK in Pak2 KO naive CD4 T cells was not affected by inducible deletion of Pak2, suggesting that proximal TCR signalling and downstream ERK signalling might not be direct targets of Pak2 in peripheral CD4 T cells (see Supplementary material, Fig. S4a) .
We next examined phosphorylation of candidate proteins that are implicated in actin cytoskeletal regulation. Cofilin, a family of actin-binding proteins that disassemble actin filaments, is known to be important for cytoskeletal reorganization, immune synapse formation and T-cell activation and migration. 22, 23 Cofilin is constitutively phosphorylated and maintained to be inactive without any stimulation in WT CD4 T cells (Fig. 5a , lane 1). TCR stimulation temporarily dephosphorylates cofilin and activates its actin severing activity to facilitate actin dynamics during T-cell stimulation (Fig. 5a,  lane 2-3) . Strikingly, phosphorylation of cofilin in Pak2 KO CD4 T cells was dramatically decreased in resting state and following TCR stimulation (Fig. 5a , lane [6] [7] [8] [9] [10] . This finding indicates that either Pak2 directly phosphorylates cofilin or participates in phosphorylation of cofilin indirectly. Either case supports the notion that Pak2 may integrate the TCR-induced actin cytoskeletal reorganization signal into the TCR-induced activation and proliferation signal through contributing to cofilin phosphorylation. Decreased phosphorylation of cofilin was accompanied by impaired mTORC1 signalling, an important signal for the proliferation and cell metabolism of CD4 T cells, 6 as phosphorylation of p70S6K and its substrate S6 were severely inhibited in Pak2 KO CD4 T cells following TCR stimulation (Fig. 5b) . Based on these data, we propose that Pak2 controls actin cytoskeletal reorganization by phosphorylating cofilin and further regulates TCR-induced activation and proliferation of CD4 T cells by affecting the mTORC1 pathway.
Discussion
Previously, we reported that Pak2 is essential for the development and maturation of T cells 12 and for the generation of Treg cells in the thymus 13 by using Cd4-Creor Lck-Cre-mediated T-cell-specific Pak2 deletion mice. Developmental defects of T cells in the thymus in these models resulted in severe T-cell deficiency, making it difficult to address the roles of Pak2 in T-cell function in the periphery. Here, we report that Pak2 has pleiotropic effects in different subsets of peripheral T cells using two independent tamoxifen-inducible Pak2-deficient mouse lines that temporarily delete Pak2 in all cells or CD4 T cells, which were otherwise developed normally in the thymus. TCR-dependent proliferation of both Treg cells and conventional T cells was affected by the inducible deletion of Pak2, suggesting that Pak2 contributes to TCR-dependent signalling events shared in both subsets of T cells. Interestingly, temporal deletion of Pak2 specifically reduced Treg cells, indicating that Pak2 is essential for the maintenance of Continuous TCR signalling and CTLA4 expression are required for the suppressive function of Treg cells. 17, 18, 24 Consistent with the finding that deletion of Pak2 decreased expression of CTLA4 in CD25 + Foxp3 + Treg cells and the cell proliferation (Fig. 2b, and 
Pak2
F/F ;Foxp3-Cre Treg cells suppressed the proliferation of CD4 + CD25 À naive conventional T cells evidenced by CFSE dilution in vitro. Furthermore, in the Treg and naive conventional T cell-transfer model of colitis using Rag1-deficient mice, mice that received conventional T cells in combination with Pak2 F/F ;Foxp3-Cre Treg cells were unable to suppress the onset of wasting disease by lacking appropriate Treg suppressive function. 25 Our results indicate that Pak2 is not essential for the maintenance of CD4 T cells but is critical for their activation and proliferation upon TCR/CD28 stimulation. Adoptive transfer experiments using a 1 : 1 mixture of WT and Pak2-deficient CD4 T cells into Rag1-deficient mice demonstrated that proliferation of Pak2-deficient CD4 T cells was significantly impaired in vivo. As cotransferred WT cells can provide IL-2, the proliferative defect of Pak2-deficent T cells was not due to paucity of IL-2. Once T cells are activated by TCR/CD28 co-stimulation, the cells produce great amounts of IL-2 and increased high-affinity IL-2 receptor, CD25. IL-2/IL-2R signalling provides a strong proliferation signal to T cells. 7, 26 Expression of IL-2 and CD25 were significantly decreased even upon TCR/CD28 stimulation in Pak2 KO CD4 T cells in vitro, and these defects were only partially rescued by exogenous IL-2. These data suggest that Pak2 provides unique TCR-mediated proliferative signals that cannot be compensated by IL-2. How does Pak2 contribute to the TCR/CD28-stimulated signalling pathway? Pak2 is a well-known effector for Rho family GTPase. Rho family GTPases Rac and Cdc42 are activated by TCR engagement and stimulate Pak2's kinase activity. 10 Pak2 is a Ser/Thr kinase that phosphorylates multiple targets. To understand the mechanism of Pak2's role in TCR signalling, it is critical to identify the substrates of Pak2. In our previous report, phosphorylation of PLCc, ERK1/2, p70S6K and S6 were impaired in Pak2-deficient thymocytes only when they are stimulated by plate-bound TCR stimulation. 12 In the current report, we demonstrated that temporal deletion of Pak2 in peripheral CD4 T cells inhibited TCRmediated phosphorylation of p70S6K and its substrate S6, but not PLCc and ERK1/2. p70S6K is activated by mTORC1 and phosphorylates S6. The mTOR-mediated signalling pathway is known to be crucial for TCRmediated cell growth, proliferation, metabolism and survival. 6 It is still unclear how Pak2 affects mTORC1 Previously, we reported that actin cytoskeletal reorganization governing T-cell spreading was severely compromised in the absence of Pak2 in CD4 single-positive thymocytes. 12 However, we could not identify which proteins among potential Pak2 substrates mediate these events. To identify the Pak2 substrates in the actin cytoskeletal reorganization pathway, we determined the phosphorylation status of multiple candidates. We did not find any difference in phosphorylation of potential Pak2 substrates including GEF-H1, LIMK and myosin light chain 10, 27 (see Supplementary material, Fig. S4b ), suggesting that these proteins may not be direct targets of Pak2. In contrast, phosphorylation of cofilin was drastically reduced in the absence of Pak2 in both resting and TCR-stimulated states, suggesting that Pak2 may be involved in constitutive phosphorylation of cofilin.
Cofilin, from a family of actin-binding proteins, depolymerizes the minus end of filaments and reorganizes actin filaments. 27, 28 Cofilin plays critical roles in immunological synapse formation by controlling actin reorganization. 29 Treatment of human peripheral blood T lymphocytes with cell-permeable cofilin peptide homologues, which showed a loss-of-function phenotype by competing with actin for cofilin binding, reduced co-stimulation-mediated cell proliferation, cytokine production and immune synapse formation. Cofilin activity is regulated by phosphorylation status at Ser3 by kinases and phosphatases including LIMK and slingshots (SSH-1 and SSH-2). 30, 31 Cofilin is maintained to be inactive in resting CD4 T cells by phosphorylation, Dephosphorylation of cofilin by TCR stimulation activates its actin severing activity to facilitate actin dynamics. In addition, oxidative stress affects cofilin activity. Oxidized cofilin is inactive although it is dephosphorylated. 32 Our data indicate that the absence of Pak2 results in dephosphorylation of cofilin without any changes in LIMK activity. The effect of Pak2 on slingshot phosphatases and oxidation of cofilin remains to be elucidated. 
